Business Wire

Toshiba Launches Powerful and Compact TCx ® 900 Point-of-Sale System

Share

The TCx® 900 is the newest point-of-sale (POS) system from global retail technology leader Toshiba Global Commerce Solutions. It provides advanced technology offerings through a powerful modular system in a compact design built to last and evolve with retailers for the long term. The system increases store productivity, enabling retailers to minimize in-store operational expenses and focus more on the business to deliver engaging shopping experiences. Generally available in September, the TCx® 900 meets the unique requirements of any retailer through powerful technological applications, including POS, store controller, and multi-store management systems.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230809756703/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

The TCx® 900 point-of-sale system boasts a retail-hardened and compact design that is built to last and evolve with retailers for the long term. (Photo: Business Wire)

“The compact TCx® 900 meets Toshiba’s retail-hardened standards of reliability, serviceability, and flexibility without compromising performance,” said Robert Parsons, Vice President Product Portfolio at Toshiba Global Commerce Solutions. “The latest hardware solution allows retailers to confidently invest in a next generation platform that can reliably support their most demanding workloads today and whatever comes next.”

The TCx® 900 enables retailers to transform their store operations while realizing unique benefits, including:

  • Power and performance withthe latest 13th Gen Intel Core processors.
  • Productivity across multiple channels is fueled by next-generation DDR5 Memory Module technology supporting better bandwidth and transaction performance.
  • Adaptability and security throughWindows and Linux OS support and enhanced digital security powered by Toshiba’s TCx® Sky operating system.
  • Flexible innovation with a rich set of customizable ports that support various input/output systems for many configurations enables retailers to modernize their front end.
  • Sustainability and efficiency through a new design that is 40% more energy efficient than industry standards and is made from PC+ABS recyclable plastics.
  • Remote monitoring and management ensuring maximum up-time, supported by Toshiba’s Proactive Availability Services.

“The retail industry is in the midst of massive technological reimagining driven by extraordinary shifts in consumer behaviors and a new normal of expectations for seamless, personalized and hyper-efficient shopper experiences," said Stacey Shulman, Vice President of Network and Edge Group at Intel. “Designed with 13th Gen Intel Core processor next generation compute performance, WiFi6 connectivity, and AI readiness, Toshiba's TCx® 900 is another example of the long history of collaboration with Intel to meet the flexible, scalable, high-performant and secure requirements retailers need to serve today's modern consumers."

The TCx® 900 is one of the latest innovations in Toshiba’s rich history and growing portfolio of end-to-end hardware, software, and service solutions. As a trusted global leader in retail technology, Toshiba is devoted to empowering retailers to better serve their communities by enabling them to evolve with generations of consumers and associates while rapidly adapting to whatever the future holds.

About Toshiba Global Commerce Solutions

Toshiba Global Commerce Solutions empowers retail to thrive and prosper through a dynamic ecosystem of smarter, more agile solutions and services that enable retailers to resiliently evolve with generations of consumers and adapt to market conditions. Supported by a global organization of devoted employees and partners, retailers gain more visibility and control over operations, while enjoying the flexibility to build, scale, and transform retail experiences that anticipate and fulfill consumers’ ever-changing needs. Visit commerce.toshiba.com and engage with us on Twitter, LinkedIn, Instagram, and YouTube to learn more.

© Intel Corporation. Intel, the Intel logo and other Intel marks are trademarks of Intel Corporation or its subsidiaries. Other names and brands may be claimed as the property of others.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Toshiba Global Commerce Solutions
Elizabeth Romero
Director, Corporate Communications
elizabeth.romero@toshibagcs.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor22.12.2025 09:00:00 CET | Press Release

Merck, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved pimicotinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause functional limitation or relatively severe morbidity. Pimicotinib, a colony stimulating factor-1 receptor (CSF-1R) inhibitor developed by Abbisko Therapeutics Co., Ltd., Shanghai, China, is the first Chemical Drug Class 1 approved in China for the treatment of TGCT. “We are continuing to deliver on our commitment to improving the lives of patients with rare tumors with this first-in-the-world regulatory approval of pimicotinib,” said Danny Bar-Zohar, CEO Healthcare and Member of the Executive Board of Merck. “This approval is a significant step forward in further strengthening our leadership in rare tumors, while offering patients the opportunity to change the course of

Incyte Japan Announces Approval of Minjuvi ® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma22.12.2025 08:44:00 CET | Press Release

Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide for adult patients with relapsed or refractory follicular lymphoma (2L+ FL). “Today's approval of Minjuvi in combination with rituximab and lenalidomide marks a significant milestone as the first dual-targeted CD19 and CD20 immunotherapy combination for relapsed or refractory FL in Japan,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “By improving progression-free survival, Minjuvi offers a chemotherapy-free option for eligible patients with relapsed or refractory disease. This approval underscores our commitment to bridging critical treatment gaps to patients and families affected by this challenging disease in Japan.” The approval is based on the pivotal Phase 3 inMIND trial, which enrolled 654 adult patients, including patients based in Japan. The study demonstrated that Minjuvi

Incyte Japan Announces Approval of Zynyz ® (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer22.12.2025 08:42:00 CET | Press Release

Incyte Biosciences Japan G.K. today announced the Japan Ministry of Health, Labour and Welfare (MHLW) approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of advanced squamous cell carcinoma of the anal canal (SCAC). "Today's approval marks a significant milestone for patients with advanced anal cancer in Japan – the MHLW’s approval of Zynyz as the first and only first-line treatment for SCAC," said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan G.K. "By offering combination therapy with chemotherapy, Zynyz provides a vital new path forward for patients facing this challenging disease, addressing a significant unmet need in cancer care for patients with SCAC and their families." The approval was based on data from the Phase 3 POD1UM-303/InterAACT2 trial evaluating Zynyz in combination with platinum-based chemotherapy (carboplatin-paclitaxel) in adult patients with metastatic or inoperable

GBC AG Analyst Coverage Report on Mexedia S.p.A. Società Benefit Completed and Published22.12.2025 08:30:00 CET | Press Release

Regulatory News: Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN IT0005450819) (“Mexedia” or the “Company”) informs that the analyst coverage report prepared by GBC AG – one of the leading independent financial research firms in Germany –, developed within an issuer-sponsored research framework, has been completed and is now publicly available. The report follows the re-initiation of analyst coverage by GBC AG previously communicated by the Company and is based exclusively on publicly available information. The content, assumptions and conclusions of the report are solely attributable to the analyst. The GBC AG analyst coverage report is available on the Company’s official website at the following address: https://mexedia.com/en/financial-statements-and-reports/ and on the analyst’s website. Daniel Gilcher, Chief Financial Officer of Mexedia S.p.A. Società Benefit, stated: “The completion and publication of the analyst coverage report by GBC AG represents the conclus

Hisense Joins HEVC Advance Patent Pool22.12.2025 03:06:00 CET | Press Release

Access Advance LLC, the global leader in video codec patent pool licensing, today announced that Hisense Group Holdings Co., Ltd. has joined the HEVC Advance Patent Pool as a Licensee. Hisense joins the recent additions to the Access Advance patent pools, including Xiaomi, MSI, Transsion, and expanded relationships with Huawei, HP and Sharp. Hisense, headquartered in Qingdao, China, is one of the world's largest television manufacturers, with a global presence spanning Asia, Europe, the Americas, and beyond. The company's products reach consumers in more than 160 countries and regions worldwide. "We are pleased to welcome Hisense to the HEVC Advance Patent Pool," said Peter Moller, CEO of Access Advance. "This agreement is the result of extensive engagement between our teams over a considerable period of time. Hisense's decision to join the pool reflects a recognition that transparent, efficient licensing solutions benefit both innovators and implementers across the video technology ec

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye